Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more
close menu × Sign Up Sign In

Retinoic acid

Available only for Premium Members
840 Number of Transfers Made
Add to Favorites
Add to IC Complex

All Trans Retinoic Acid (ATRA) is FDA approved in the treatment of promyelocytic leukemia. ATRA is a strong differentiating agent. As such, ATRA has potential as a therapy in a number of cancers, especially in the context of IC medicines. ATRA binds to retinoic acid receptors, and subsequently activates DNA transcription activity to move immature (e.g. malignant) cells toward normal maturation. Consider the use of ATRA in cases of cancer and precancerous lesions, including polyps, actinic keratosis, and others.

For: People
IC Source: Allopathy
For: Mitochondrial and Energy Production System
For: Blood and Cardiovascular System
For: Immune System and Lymphatic System
For: Integumentary System